CN106011099A - Separation and purification method of insect transglutaminase - Google Patents
Separation and purification method of insect transglutaminase Download PDFInfo
- Publication number
- CN106011099A CN106011099A CN201610458931.5A CN201610458931A CN106011099A CN 106011099 A CN106011099 A CN 106011099A CN 201610458931 A CN201610458931 A CN 201610458931A CN 106011099 A CN106011099 A CN 106011099A
- Authority
- CN
- China
- Prior art keywords
- transglutaminase
- target protein
- tris
- insect
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 27
- 108060008539 Transglutaminase Proteins 0.000 title abstract description 93
- 102000003601 transglutaminase Human genes 0.000 title abstract description 92
- 241000238631 Hexapoda Species 0.000 title abstract description 23
- 238000000926 separation method Methods 0.000 title abstract description 19
- 238000000746 purification Methods 0.000 title abstract description 6
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 54
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 54
- 238000005342 ion exchange Methods 0.000 claims abstract description 20
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 13
- 238000004440 column chromatography Methods 0.000 claims abstract description 13
- 239000008103 glucose Substances 0.000 claims abstract description 13
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims abstract description 12
- 235000011130 ammonium sulphate Nutrition 0.000 claims abstract description 12
- 241000607479 Yersinia pestis Species 0.000 claims abstract description 10
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 30
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 26
- 229920005654 Sephadex Polymers 0.000 claims description 23
- 102000004190 Enzymes Human genes 0.000 claims description 22
- 108090000790 Enzymes Proteins 0.000 claims description 22
- 239000012507 Sephadex™ Substances 0.000 claims description 21
- 239000000872 buffer Substances 0.000 claims description 14
- 239000007853 buffer solution Substances 0.000 claims description 13
- 239000011780 sodium chloride Substances 0.000 claims description 13
- 239000003480 eluent Substances 0.000 claims description 10
- 241001477931 Mythimna unipuncta Species 0.000 claims description 7
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 7
- 238000004255 ion exchange chromatography Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 241000255925 Diptera Species 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 241000254173 Coleoptera Species 0.000 claims description 2
- 241000258937 Hemiptera Species 0.000 claims description 2
- 241000255777 Lepidoptera Species 0.000 claims description 2
- 241000238814 Orthoptera Species 0.000 claims description 2
- 150000002500 ions Chemical group 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000002917 insecticide Substances 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 238000004140 cleaning Methods 0.000 claims 1
- 238000000975 co-precipitation Methods 0.000 claims 1
- 235000011149 sulphuric acid Nutrition 0.000 claims 1
- 239000001117 sulphuric acid Substances 0.000 claims 1
- 238000001556 precipitation Methods 0.000 abstract description 6
- 238000011160 research Methods 0.000 abstract description 5
- 230000007180 physiological regulation Effects 0.000 abstract description 4
- 230000000749 insecticidal effect Effects 0.000 abstract description 3
- 238000012827 research and development Methods 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 40
- 230000000694 effects Effects 0.000 description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 238000004587 chromatography analysis Methods 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000010828 elution Methods 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 7
- 238000000502 dialysis Methods 0.000 description 7
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 6
- 239000008367 deionised water Substances 0.000 description 5
- 229910021641 deionized water Inorganic materials 0.000 description 5
- 238000005227 gel permeation chromatography Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 4
- 238000011067 equilibration Methods 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 241000256182 Anopheles gambiae Species 0.000 description 2
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000006920 protein precipitation Effects 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 108700002304 Drosophila can Proteins 0.000 description 1
- 241000255601 Drosophila melanogaster Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 208000023105 Huntington disease Diseases 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 102100030944 Protein-glutamine gamma-glutamyltransferase K Human genes 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- -1 benzylcarbonyl Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940044631 ferric chloride hexahydrate Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000007124 immune defense Effects 0.000 description 1
- 230000037189 immune system physiology Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- NQXWGWZJXJUMQB-UHFFFAOYSA-K iron trichloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].Cl[Fe+]Cl NQXWGWZJXJUMQB-UHFFFAOYSA-K 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 239000012146 running buffer Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000005891 transamination reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/104—Aminoacyltransferases (2.3.2)
- C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/02—Aminoacyltransferases (2.3.2)
- C12Y203/02013—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
本发明涉及一种昆虫谷氨酰胺转胺酶(Transglutaminase)的分离纯化方法。所述分离纯化方法包括(1)制备昆虫谷氨酰胺转胺酶的步骤;(2)采用硫酸铵,通过沉淀方式分离由步骤(1)所得的昆虫谷氨酰胺转胺酶,得到初步目标蛋白的步骤;(3)初步目标蛋白依次经葡萄糖凝胶柱和离子交换柱层析,得到目标蛋白的步骤;或,初步目标蛋白依次经离子交换柱和葡萄糖凝胶柱层析,得到目标蛋白的步骤。本发明首次成功分离纯化了昆虫谷氨酰胺转胺酶,为以谷氨酰胺转氨酶为作用靶标的害虫生理调控研究及以谷氨酰胺转氨酶为作用靶标的新型害虫防治或杀虫手段的研发奠定了基础。
The invention relates to a method for separating and purifying insect Transglutaminase. The separation and purification method includes (1) the step of preparing insect transglutaminase; (2) using ammonium sulfate to separate the insect transglutaminase obtained in step (1) by precipitation to obtain a preliminary target protein (3) the step of obtaining the target protein through glucose gel column and ion exchange column chromatography in turn for the preliminary target protein; or, the step of obtaining the target protein through ion exchange column and glucose gel column chromatography in turn for the preliminary target protein step. The invention successfully separates and purifies insect transglutaminase for the first time, which lays a foundation for the research on the physiological regulation of pests with transglutaminase as the target and the research and development of new pest control or insecticidal methods with transglutaminase as the target Base.
Description
技术领域technical field
本发明涉及一种昆虫谷氨酰胺转胺酶(Transglutaminase)的分离纯化方法。The invention relates to a method for separating and purifying insect Transglutaminase.
背景技术Background technique
谷氨酰胺转胺酶(Transglutaminase,EC 2.3.2.13)能催化谷氨酰胺肽键的γ-甲酰胺基团与赖氨酸肽键的ε-氨基基团发生酰基转移反应,形成ε-(γ-谷氨酰基)氨酸异肽键。能特异性地识别谷氨酰胺类蛋白底物,并对胺类酰基受体的特异性较低,赖氨酸肽键的ε-氨基基团或低分子聚合的伯胺都可以作为反应的酰基受体。具有催化蛋白质分子间或分子内的交联反应、氨基酸与蛋白质之间的连接、以及蛋白质分子内谷氨酰胺基的水解等优良的催化性能。Transglutaminase (Transglutaminase, EC 2.3.2.13) can catalyze the acyl transfer reaction between the γ-formamide group of the glutamine peptide bond and the ε-amino group of the lysine peptide bond to form ε-(γ -glutamyl) acid isopeptide bond. It can specifically recognize glutamine-like protein substrates, and has low specificity for amine-like acyl receptors. The ε-amino group of the lysine-peptide bond or the primary amine of low-molecular polymerization can be used as the reactive acyl group receptor. It has excellent catalytic properties such as catalyzing the cross-linking reaction between protein molecules or within the molecule, the connection between amino acids and proteins, and the hydrolysis of glutamine groups in protein molecules.
在哺乳动物中,谷氨酰胺转胺酶参与凝血、免疫防御、细胞分化和凋亡、炎性自身免疫和神经退行性疾病等过程。被用于外创伤、骨折和软骨病变的修复以及某些肠道疾病的治疗和自身免疫抗原,还被用于许多重大疾病(如:白内障、动脉硬化症、阿尔茨海默式、亨廷顿氏病、帕金森病等)的调控过程。目前,谷氨酰胺转胺酶在食品、化妆品和医药等领域中有着极其广泛的应用价值。In mammals, transglutaminase is involved in processes such as coagulation, immune defense, cell differentiation and apoptosis, inflammatory autoimmunity and neurodegenerative diseases. It is used for the repair of external trauma, fractures and cartilage lesions, as well as the treatment of certain intestinal diseases and autoimmune antigens, and is also used for many major diseases (such as: cataract, arteriosclerosis, Alzheimer's, Huntington's disease , Parkinson's disease, etc.) regulation process. At present, transglutaminase has extremely wide application value in the fields of food, cosmetics and medicine.
研究谷氨酰胺转胺酶发现:在微生物、植物、无脊椎动物、两栖动物、鱼类、鸟类等物种中均存在谷氨酰胺转胺酶。但是,不同来源谷氨酰胺转胺酶不仅在酶学性质如:分子量、等电点、最适pH值、最适温度等方面存在较大差异,而且在蛋白结构、氨基酸序列、空间结构、活性等方面也存在差异。其中,微生物来源的谷氨酰胺转胺酶分子量普遍较小,以40kDa居多,约为哺乳动物谷氨酰胺转胺酶分子量的一半。不同来源谷氨酰胺转胺酶的共同点在于:蛋白活性中心都有Cys残基,酶的催化三联体具有高度保守性。Research on transglutaminase found that transglutaminase exists in microorganisms, plants, invertebrates, amphibians, fish, birds and other species. However, transglutaminases from different sources not only have great differences in enzymatic properties such as: molecular weight, isoelectric point, optimum pH value, optimum temperature, etc., but also have great differences in protein structure, amino acid sequence, spatial structure, activity, etc. There are also differences. Among them, the molecular weight of transglutaminase derived from microorganisms is generally small, mostly 40 kDa, which is about half of the molecular weight of mammalian transglutaminase. The common point of transglutaminases from different sources is that the active center of the protein has Cys residues, and the catalytic triad of the enzyme is highly conserved.
在自然条件下,谷氨酰胺转胺酶容易形成不可逆的聚合物,因而很难分离纯化。另外,保持谷氨酰胺转胺酶的稳定性和建立灵敏度高的酶活检测方法也是分离纯化谷氨酰胺转胺酶过程中需解决的一大难点。Under natural conditions, transglutaminase easily forms irreversible polymers, which are difficult to isolate and purify. In addition, maintaining the stability of transglutaminase and establishing a highly sensitive enzyme activity detection method are also major difficulties to be solved in the process of separating and purifying transglutaminase.
尽管已发现谷氨酰胺转胺酶广泛分布于昆虫肌肉和细胞中,但昆虫谷氨酰胺转胺酶的特性被报道较少,目前主要集中在果蝇(Drosophila melanogaster)和冈比亚按蚊(Anopheles gambiae)等虫媒的谷氨酰胺转胺酶。据报道,果蝇体内谷氨酰胺转胺酶参与血浆凝结的形成,敲除果蝇的谷氨酰胺转胺酶基因能显著降低果蝇体内谷氨酰胺转胺酶的表达水平,幼虫更容 易受到外源病原真菌和细菌的感染,显著增加幼虫感染性死亡率;在冈比亚按蚊体内,谷氨酰胺转胺酶可能参与其生育和免疫生理的调控。Although transglutaminase has been found to be widely distributed in insect muscles and cells, the characteristics of insect transglutaminase have been reported less, and currently mainly focus on Drosophila melanogaster and Anopheles gambiae ) and other insect-borne transglutaminases. It has been reported that transglutaminase in Drosophila is involved in the formation of plasma coagulation, knocking out the transglutaminase gene in Drosophila can significantly reduce the expression level of transglutaminase in Drosophila, and larvae are more susceptible to Infection with exogenous pathogenic fungi and bacteria significantly increases the infectious mortality of larvae; in Anopheles gambiae, transglutaminase may be involved in the regulation of reproductive and immune physiology.
对昆虫谷氨酰胺转胺酶认识的局限性,极大地限制了以谷氨酰胺转胺酶为作用靶标的害虫生理调控研究和新型害虫防治或杀虫手段的研发。但是,到目前为止,有关昆虫谷氨酰胺转胺酶的分离纯化过程尚未见文献报道。The limitation of understanding of insect transglutaminase has greatly restricted the research on the physiological regulation of pests and the development of new pest control or insecticidal methods with transglutaminase as the target. However, so far, the isolation and purification process of insect transglutaminase has not been reported in the literature.
发明内容Contents of the invention
为了解决上述以谷氨酰胺转胺酶为作用靶标的害虫生理调控研究和新型害虫管理手段的研发,进一步深化认识昆虫谷氨酰胺转胺酶的难题,本发明的目的在于:提供一种昆虫谷氨酰胺转胺酶的分离纯化方法。In order to solve the above-mentioned pest physiological regulation research and the research and development of new pest management methods with transglutaminase as the target, and further deepen the difficult problem of understanding insect transglutaminase, the object of the present invention is to: provide an insect cereal A method for separation and purification of aminotransferase.
本发明所述昆虫谷氨酰胺转胺酶的分离纯化方法,其包括如下步骤:The separation and purification method of insect transglutaminase of the present invention, it comprises the steps:
(1)制备昆虫谷氨酰胺转胺酶的步骤;(1) the step of preparing insect transglutaminase;
(2)采用硫酸铵,通过沉淀方式分离由步骤(1)所得的昆虫谷氨酰胺转胺酶,得到初步目标蛋白的步骤;和,(2) using ammonium sulfate to separate the insect transglutaminase obtained in step (1) by precipitation to obtain a preliminary target protein; and,
(3)初步目标蛋白依次经葡萄糖凝胶柱和离子交换柱层析,得到目标蛋白的步骤;或,初步目标蛋白依次经离子交换柱和葡萄糖凝胶柱层析,得到目标蛋白的步骤;(3) the step of obtaining the target protein through sequential chromatography on glucose gel column and ion exchange column for the preliminary target protein; or, the step of obtaining the target protein through sequential chromatography on ion exchange column and glucose gel column for the preliminary target protein;
其中,所述昆虫为鳞翅目、直翅目、鞘翅目、双翅目、同翅目或双翅目等害虫,所述葡萄糖凝胶柱分离范围为3,000~150,000。Wherein, the insects are pests of Lepidoptera, Orthoptera, Coleoptera, Diptera, Homoptera or Diptera, and the separation range of the glucose gel column is 3,000-150,000.
附图说明Description of drawings
图1经不同饱和度硫酸铵沉淀后样品中谷氨酰胺转氨酶比活力。Figure 1 Specific activity of transglutaminase in samples after ammonium sulfate precipitation with different saturation degrees.
图2谷氨酰胺转胺酶的Sephadex G-75葡聚糖凝胶分离。Figure 2 Sephadex G-75 sephadex separation of transglutaminase.
图3谷氨酰胺转胺酶的Sephadex G-100葡聚糖凝胶分离。Figure 3 Sephadex G-100 sephadex separation of transglutaminase.
图4 pH7.8的Tris-HCl缓冲液对谷氨酰胺转胺酶的离子交换层析洗脱分离;The Tris-HCl buffer solution of Fig. 4 pH7.8 is to the ion-exchange chromatography elution separation of transglutaminase;
图中:各泳道对应于4个具有谷氨酰胺转胺酶活性的蛋白样品。In the figure: each lane corresponds to 4 protein samples with transglutaminase activity.
图5 pH8.5的Tris-HCl缓冲液对谷氨酰胺转胺酶的离子交换层析洗脱分离。Fig. 5 Tris-HCl buffer solution at pH 8.5 for ion-exchange chromatography elution separation of transglutaminase.
图6谷氨酰胺转胺酶经方法1纯化后的凝胶电泳图谱;The gel electrophoresis pattern of Fig. 6 transglutaminase purified by method 1;
图中:M—标准蛋白;TG—目标蛋白。In the figure: M—standard protein; TG—target protein.
图7谷氨酰胺转胺酶经方法2纯化后的凝胶电泳图谱;The gel electrophoresis pattern of Fig. 7 transglutaminase purified by method 2;
图中:M—标准蛋白;1—粗酶液;2—硫酸铵沉淀后酶液;3—第一次离子交换沉析后酶液;4—第二次离子交换沉析后酶液;5—凝胶层析后酶液。In the figure: M—standard protein; 1—crude enzyme solution; 2—enzyme solution after ammonium sulfate precipitation; 3—enzyme solution after the first ion exchange precipitation; 4—enzyme solution after the second ion exchange precipitation; 5 - Enzyme solution after gel chromatography.
具体实施方式detailed description
在本发明一个优选的技术方案中,采用55%饱和度的硫酸铵,通过沉淀方式分离由步骤(1)所得的昆虫谷氨酰胺转胺酶,得到初步目标蛋白。In a preferred technical solution of the present invention, ammonium sulfate with 55% saturation is used to separate the insect transglutaminase obtained in step (1) by precipitation to obtain a preliminary target protein.
在本发明另一个优选的技术方案中,步骤(3)中,当初步目标蛋白采用先经离子交换柱层析,再经葡萄糖凝胶柱层析时,需经两次离子交换柱层析,再经葡萄糖凝胶柱层析;In another preferred technical solution of the present invention, in step (3), when the primary target protein is first subjected to ion-exchange column chromatography and then glucose gel column chromatography, it needs to be subjected to ion-exchange column chromatography twice, Then through glucose gel column chromatography;
在本发明又一个优选的技术方案中,步骤(3)中所用葡萄糖凝胶柱为Sephadex G-100凝胶柱(分离范围4,000-150,000)。In yet another preferred technical solution of the present invention, the glucose gel column used in step (3) is a Sephadex G-100 gel column (separation range 4,000-150,000).
在本发明又一个优选的技术方案中,步骤(3)中所用离子交换柱为DEAE-纤维素-52离子交换柱,所用洗脱液是:pH值为7.0~9.0(更优选7.8~8.5)、浓度为15mM~25mM的Tris-HCl缓冲液,且在所述Tris-HCl缓冲液含有0~1.0M NaCl(更优选0.2M~0.8M)。In yet another preferred technical solution of the present invention, the ion exchange column used in step (3) is a DEAE-cellulose-52 ion exchange column, and the eluent used is: the pH value is 7.0~9.0 (more preferably 7.8~8.5) . Tris-HCl buffer solution with a concentration of 15mM-25mM, and the Tris-HCl buffer solution contains 0-1.0M NaCl (more preferably 0.2M-0.8M).
本发明的发明人首次成功分离纯化了昆虫谷氨酰胺转胺酶,为以谷氨酰胺转氨酶为作用靶标的害虫生理调控研究及以谷氨酰胺转氨酶为作用靶标的新型害虫防治或杀虫手段的研发奠定了基础。The inventors of the present invention successfully separated and purified insect transglutaminase for the first time, which is the basis for the research on the physiological regulation of pests with transglutaminase as the target and the new pest control or insecticidal means with transglutaminase as the target R&D laid the groundwork.
下面结合实施例对本发明做进一步阐述,其目的仅在于更好理解本发明的内容。因此,所举之例不限制本发明的保护范围。The present invention is described further below in conjunction with embodiment, and its purpose is only to understand content of the present invention better. Therefore, the examples given do not limit the protection scope of the present invention.
实施例1Example 1
昆虫谷氨酰胺转胺酶的制备Preparation of Insect Transglutaminase
实验方法:experimental method:
(1)取大小均一的四龄粘虫幼虫若干头,饥饿处理4h后,用20mM Tris-HCl缓冲液(pH8.0)清洗虫体。(1) Several fourth-instar armyworm larvae of uniform size were taken, starved for 4 hours, and washed with 20 mM Tris-HCl buffer solution (pH 8.0).
(2)按照体积比3:1(v:v),(缓冲液∶幼虫的体积比为3∶1)将幼虫置于20mM Tris-HCl缓冲液(pH8.0)中,冰浴条件下,静置30min后,充分匀浆。(2) According to the volume ratio of 3:1 (v:v), (the volume ratio of buffer: larvae is 3:1), the larvae were placed in 20mM Tris-HCl buffer (pH8.0), under ice bath conditions, After standing still for 30min, fully homogenate.
(3)待虫体充分破碎后,将匀浆液离心(10,000g,4℃)20min,取上清液进行冷冻干燥,收集干粉,用作谷氨酰胺转胺酶的酶源。(3) After the worms were fully broken, the homogenate was centrifuged (10,000 g, 4° C.) for 20 min, the supernatant was taken for freeze-drying, and the dry powder was collected to be used as an enzyme source of transglutaminase.
(4)测定谷氨酰胺转胺酶的活力。取100μl预热至37℃的苯甲基氧化碳酰-L-谷氨酰胺甘氨酸(Nα-CBZ-GIn-Gly)底物溶液(配制方法:称取100mg Nα-CBZ-GIn-Gly溶于2mL的0.2mol/L NaOH溶液中,完全溶解后加入4mL的0.2M Tris-HCl(pH 6.0)缓冲液、2mL的0.1M羟胺溶液和2mL的0.01M还原型谷胱甘肽溶液,并调节pH为6.0),加入50μl酶液,37℃水浴温度下反应10min,加入100μl TCA显色液(由3M HCl、12%三氯乙酸、5%六水三氯化铁按照1:1:1等体积混合而成)使反应终止,常温离心(8,000g)5min后,取上清液置于酶标仪中波长为525nm 处读取吸光度值(OD525),依据标准曲线计算出谷氨酰胺转胺酶的比活力。以不添加Nα-CBZ-GIn-Gly的底物溶液为对照。(4) Determination of the activity of transglutaminase. Take 100 μl of benzylcarbonyl oxide-L-glutamine glycine (N α -CBZ-GIn-Gly) substrate solution preheated to 37°C (preparation method: weigh 100 mg of N α -CBZ-GIn-Gly solution In 2mL of 0.2mol/L NaOH solution, after completely dissolving, add 4mL of 0.2M Tris-HCl (pH 6.0) buffer solution, 2mL of 0.1M hydroxylamine solution and 2mL of 0.01M reduced glutathione solution, and adjust pH is 6.0), add 50 μl enzyme solution, react at 37°C water bath temperature for 10 minutes, add 100 μl TCA color development solution (made from 3M HCl, 12% trichloroacetic acid, 5% ferric chloride hexahydrate according to 1:1:1, etc. volume mixed) to terminate the reaction, centrifuge at room temperature (8,000g) for 5 minutes, take the supernatant and place it in a microplate reader at a wavelength of 525nm to read the absorbance value (OD 525 ), and calculate the glutamine transamination according to the standard curve Enzyme specific activity. The substrate solution without adding N α -CBZ-GIn-Gly was used as the control.
实验结果:Experimental results:
结果表明(表1),粘虫体内存在谷氨酰胺转胺酶,且谷氨酰胺转胺酶的总活性随着酶源样品中蛋白含量的增加而逐渐增加,但谷氨酰胺转胺酶的比活力较低,表明粘虫体内谷氨酰胺转胺酶的含量较低。The results showed (Table 1) that there was transglutaminase in the armyworm, and the total activity of transglutaminase gradually increased with the increase of protein content in the enzyme source sample, but the activity of transglutaminase The lower specific activity indicated that the content of transglutaminase in armyworms was lower.
表1虫体酶源样品中谷氨酰胺转胺酶的比活力Table 1 Specific activity of transglutaminase in parasite enzyme source samples
实施例2Example 2
昆虫谷氨酰胺转胺酶的硫酸铵沉淀分离Ammonium Sulfate Precipitation Separation of Insect Transglutaminase
实验方法:experimental method:
(1)将粘虫匀浆液在冰浴条件下缓慢加入硫酸铵固体,分别至饱和度为25%、35%、45%、55%、65%、75%、85%,用玻璃棒搅拌均匀,待硫酸铵固体彻底溶解后继续搅拌30min,4℃下静置过夜后,离心(10,000g,4℃)30min,收集上清液和沉淀。(1) Slowly add solid ammonium sulfate to the armyworm homogenate in an ice bath until the saturation is 25%, 35%, 45%, 55%, 65%, 75%, and 85%, and stir evenly with a glass rod After the ammonium sulfate solid was completely dissolved, continue to stir for 30 minutes, and after standing overnight at 4°C, centrifuge (10,000g, 4°C) for 30 minutes to collect the supernatant and precipitate.
(2)将沉淀溶于20mM Tris-HCl缓冲液(pH8.0)中,与上清液一样分别转移入透析袋,置于4℃流动缓冲液中透析过夜,至1%BaCl溶液检测确定透析液中没有硫酸铵后停止透析,取酶液进行冷冻干燥。(2) Dissolve the precipitate in 20mM Tris-HCl buffer solution (pH 8.0), transfer it into dialysis bags like the supernatant, place it in 4°C running buffer and dialyze overnight, and check the 1% BaCl solution to confirm the dialysis The dialysis was stopped when there was no ammonium sulfate in the solution, and the enzyme solution was taken for freeze-drying.
(3)测定谷氨酰胺转胺酶的比活力。(3) Determination of the specific activity of transglutaminase.
实验结果:Experimental results:
结果表明(图1),在硫酸铵溶液的饱和度达到55%,样品的沉淀中谷氨酰胺转胺酶比活力达到最大,而样品的上清液中谷氨酰胺转胺酶比活力显著降低,表明采用55%饱和度的硫酸铵沉淀样品中谷氨酰胺转胺酶的效果最佳。The result shows (Fig. 1), reaches 55% in the saturation degree of ammonium sulfate solution, and the transglutaminase specific activity reaches maximum in the precipitation of sample, and in the supernatant of sample, transglutaminase specific activity significantly reduces, shows Precipitating transglutaminase from samples with 55% saturation ammonium sulfate works best.
实施例3Example 3
昆虫谷氨酰胺转胺酶的Sephadex G-75葡聚糖凝胶分离Sephadex G-75 Sephadex Gel Separation of Insect Transglutaminase
实验方法:experimental method:
(1)取50g Sephadex G-75葡聚糖凝胶(分离范围3,000-80,000)加入2L去离子水中,搅拌均匀后,室温下静置溶胀过夜,然后置于沸水中溶胀4h,冷却后备用。(1) Take 50g of Sephadex G-75 dextran gel (separation range 3,000-80,000) into 2L of deionized water, stir evenly, let stand at room temperature to swell overnight, then swell in boiling water for 4 hours, cool down and set aside.
(2)将溶胀好的凝胶一次性装入层析柱(1.6×100cm)内,加入3倍柱床体积的20mMTris-HCl(pH 8.0)缓冲液进行平衡。(2) The swollen gel was loaded into a chromatography column (1.6×100 cm) at one time, and 20 mM Tris-HCl (pH 8.0) buffer solution of 3 times the volume of the column bed was added for equilibration.
(3)待平衡液与凝胶液面约1cm处时,取酶液进行上样,待酶液全部进入胶面后,加入20mM Tris-HCl(pH 8.0)缓冲液进行洗脱,调节流速为0.5mL/min,收集流出组分,测定各组分在波长为280nm处的吸收值,(3) When the level of the equilibrium solution and the gel is about 1cm away, take the enzyme solution to load the sample. After the enzyme solution has completely entered the gel surface, add 20mM Tris-HCl (pH 8.0) buffer to elute, and adjust the flow rate to 0.5mL/min, collect the effluent components, measure the absorption value of each component at a wavelength of 280nm,
(4)测定各馏分样品中谷氨酰胺转胺酶的比活力。(4) Measure the specific activity of transglutaminase in each fraction sample.
(5)样品进行聚丙烯酰胺凝胶电泳(SDS-PAGE)。采用12%的分离胶(3.36mlddH2O,2.5ml 1.5M Tris-HCl(pH8.8),100μl 10%SDS,4ml 30%聚丙烯酰胺,25μl 10%过硫酸铵,15μl TEMED)和4%的浓缩胶(2.4ml ddH2O,1.0ml 0.5M Tris-HCl(pH6.8),40μl10%SDS,0.53ml30%聚丙烯酰胺,15μl 10%过硫酸铵,10μl TEMED)。浓缩胶电压为80V,分离胶电压为120V。采用0.1%考马斯亮蓝R250染色液对凝胶进行染色,采用脱色液(水:甲醇:冰醋酸8:1:1)对染色后的凝胶进行脱色。(5) The samples were subjected to polyacrylamide gel electrophoresis (SDS-PAGE). Using 12% separating gel (3.36mlddH 2 O, 2.5ml 1.5M Tris-HCl (pH8.8), 100μl 10% SDS, 4ml 30% polyacrylamide, 25μl 10% ammonium persulfate, 15μl TEMED) and 4% Stacking gel (2.4ml ddH 2 O, 1.0ml 0.5M Tris-HCl (pH6.8), 40μl 10% SDS, 0.53ml 30% polyacrylamide, 15μl 10% ammonium persulfate, 10μl TEMED). The voltage of the stacking gel was 80V, and the voltage of the separating gel was 120V. The gel was stained with 0.1% Coomassie Brilliant Blue R250 staining solution, and the stained gel was decolorized with a decolorizing solution (water:methanol:glacial acetic acid 8:1:1).
实验结果:Experimental results:
结果表明,在Sephadex G-75凝胶层析中,谷氨酰胺转胺酶活性集中在13-20号管(图2A)。在SDS-PAGE图谱中,谷氨酰胺转胺酶的分子量约为63.31kDa,表明谷氨酰胺转胺酶蛋白在Sephadex G-75的分离范围内,但是经Sephadex G-75凝胶层析后,目的蛋白样品中仍含较多杂蛋白(图2B)。The results showed that transglutaminase activity was concentrated in tubes 13-20 in Sephadex G-75 gel chromatography (Fig. 2A). In the SDS-PAGE pattern, the molecular weight of transglutaminase is about 63.31kDa, showing that transglutaminase protein is within the separation range of Sephadex G-75, but after Sephadex G-75 gel chromatography, The target protein sample still contained more miscellaneous proteins (Figure 2B).
实施例4Example 4
昆虫谷氨酰胺转胺酶的Sephadex G-100葡聚糖凝胶分离Sephadex G-100 Sephadex Separation of Insect Transglutaminase
实验方法:experimental method:
(1)取50g Sephadex G-100葡聚糖凝胶(分离范围4,000-150,000)加入2L去离子水中,搅拌均匀后,室温下静置溶胀过夜,然后置于沸水中溶胀4h,冷却后备用。(1) Take 50g of Sephadex G-100 dextran gel (separation range: 4,000-150,000) into 2L of deionized water, stir well, let stand at room temperature to swell overnight, then place in boiling water to swell for 4 hours, cool down and set aside.
(2)将溶胀好的凝胶一次性装入层析柱(1.6×100cm)内,加入3倍柱床体积的20mMTris-HCl(pH 8.0)缓冲液进行平衡。(2) The swollen gel was loaded into a chromatography column (1.6×100 cm) at one time, and 20 mM Tris-HCl (pH 8.0) buffer solution of 3 times the volume of the column bed was added for equilibration.
(3)待平衡液与凝胶液面约1cm处时,取酶液进行上样,待酶液全部进入胶面后,加入20mM Tris-HCl(pH 8.0)缓冲液进行洗脱,调节流速为0.5mL/min,收集流出组分,测定各组分在波长为280nm处的吸收值,(3) When the level of the equilibrium solution and the gel is about 1cm away, take the enzyme solution to load the sample. After the enzyme solution has completely entered the gel surface, add 20mM Tris-HCl (pH 8.0) buffer to elute, and adjust the flow rate to 0.5mL/min, collect the effluent components, measure the absorption value of each component at a wavelength of 280nm,
(4)测定各馏分样品中谷氨酰胺转胺酶的比活力。(4) Measure the specific activity of transglutaminase in each fraction sample.
实验结果:Experimental results:
结果表明(图3),在Sephadex G-100凝胶层析中,谷氨酰胺转胺酶活性集中在7-11号管,表明谷氨酰胺转胺酶蛋白在Sephadex G-100的分离范围内,且蛋白洗脱的峰形优于Sephadex G-75洗脱峰。The results showed (Figure 3) that in Sephadex G-100 gel chromatography, transglutaminase activity was concentrated in tubes 7-11, indicating that the transglutaminase protein was within the separation range of Sephadex G-100 , and the peak shape of protein elution is better than that of Sephadex G-75 elution peak.
实施例5Example 5
pH7.8的Tris-HCl缓冲液进行谷氨酰胺转胺酶的离子交换层析分离Ion Exchange Chromatography Separation of Transglutaminase in Tris-HCl Buffer at pH 7.8
实验方法:experimental method:
(1)取30g DEAE-纤维素-52溶于2L去离子水中,搅拌均匀后,室温下静置溶胀过夜,抽滤去除去离子水,置于0.5M NaOH溶液中浸泡30min,抽滤去除上层液,用去离子水洗至中性。然后再置于0.5M HCl溶液中30min,抽滤并水洗至中性,最后再置于0.5M NaOH溶液中浸泡30min,抽滤并水洗至中性。(1) Dissolve 30g of DEAE-cellulose-52 in 2L of deionized water, stir well, let stand at room temperature to swell overnight, remove the deionized water by suction filtration, soak in 0.5M NaOH solution for 30min, and remove the upper layer by suction filtration solution, washed with deionized water until neutral. Then put it in 0.5M HCl solution for 30 minutes, filter it with suction and wash it with water until neutral, and finally put it in 0.5M NaOH solution for 30 minutes, filter it with suction and wash it with water until it becomes neutral.
(2)将溶胀好的DEAE-纤维素-52一次性装入层析柱(3.9×20cm)内,加入3倍柱床体积的20mM Tris-HCl缓冲液(pH7.8)进行平衡。(2) The swollen DEAE-cellulose-52 was loaded into a chromatographic column (3.9×20 cm) at one time, and 20 mM Tris-HCl buffer solution (pH 7.8) of 3 times the column bed volume was added for equilibration.
(3)待平衡液与凝胶液面约1cm处时,取酶液进行上样,待酶液全部进入胶面后,用含有0-1.0M NaCl的20mM Tris-HCl缓冲液(pH7.8)进行梯度洗脱,调节流速为0.5mL/min,收集流出组分,测定各组分在波长为280nm处的吸收值。(3) When the level of the equilibrium solution and the gel liquid is about 1cm away, take the enzyme solution to load the sample. After the enzyme solution has completely entered the gel surface, use 20mM Tris-HCl buffer (pH7.8) containing 0-1.0M NaCl ) to carry out gradient elution, adjust the flow rate to 0.5mL/min, collect the effluent components, and measure the absorption value of each component at a wavelength of 280nm.
(4)测定各组分中谷氨酰胺转胺酶的比活力。(4) Measure the specific activity of transglutaminase in each component.
(5)含有谷氨酰胺转胺酶活性的样品进行聚丙烯酰胺凝胶电泳。(5) The samples containing transglutaminase activity were subjected to polyacrylamide gel electrophoresis.
实验结果:Experimental results:
结果表明,采用pH7.8的20mM Tris-HCl洗脱液进行洗脱时,离子交换柱层析能检测到四个具有谷氨酰胺转胺酶活性的且紧密相邻的蛋白吸收峰,峰值界限不明显(图4A)。聚丙烯酰胺凝胶电泳图谱显示,这四个具有谷氨酰胺转胺酶活性的蛋白样品中仍存在较多杂蛋白,且杂蛋白条带与谷氨酰胺转胺酶条带距离较近(图4B)。The results show that when the 20mM Tris-HCl eluent of pH 7.8 is used for elution, ion exchange column chromatography can detect four protein absorption peaks with transglutaminase activity and closely adjacent to each other. Not obvious (Fig. 4A). The polyacrylamide gel electrophoresis patterns showed that there were still many miscellaneous proteins in these four protein samples with transglutaminase activity, and the bands of miscellaneous proteins were relatively close to the bands of transglutaminase (Fig. 4B).
实施例6Example 6
pH8.5的Tris-HCl缓冲液进行谷氨酰胺转胺酶的离子交换层析分离Ion Exchange Chromatography Separation of Transglutaminase in Tris-HCl Buffer at pH 8.5
实验方法:experimental method:
(1)取30g DEAE-纤维素-52按照实施例5方法进行溶胀处理。(1) Take 30 g of DEAE-cellulose-52 and carry out swelling treatment according to the method in Example 5.
(2)将溶胀好的DEAE-纤维素-52一次性装入层析柱(3.9×20cm)内,加入3倍柱床体积的20mM Tris-HCl缓冲液(pH8.5)进行平衡。(2) Pack the swollen DEAE-cellulose-52 into a chromatography column (3.9×20 cm) at one time, and add 20 mM Tris-HCl buffer solution (pH 8.5) of 3 times the column bed volume for equilibration.
(3)待平衡液与凝胶液面约1cm处时,取酶液进行上样,待酶液全部进入胶面后,用含有0-1.0M NaCl的20mM Tris-HCl缓冲液(pH8.5)进行梯度洗脱,调节流速为0.5mL/min,收集流出组分,测定各组分在波长为280nm处的吸收值。(3) When the level of the equilibrium solution and the gel liquid is about 1cm away, take the enzyme solution to load the sample. After the enzyme solution has completely entered the gel surface, use 20mM Tris-HCl buffer (pH8.5) containing 0-1.0M NaCl ) to carry out gradient elution, adjust the flow rate to 0.5mL/min, collect the effluent components, and measure the absorption value of each component at a wavelength of 280nm.
(4)测定各组分中谷氨酰胺转胺酶的比活力。(4) Measure the specific activity of transglutaminase in each component.
(5)含有谷氨酰胺转胺酶活性的样品进行聚丙烯酰胺凝胶电泳。(5) The samples containing transglutaminase activity were subjected to polyacrylamide gel electrophoresis.
实验结果:Experimental results:
结果表明,采用pH8.5的20mM Tris-HCl洗脱液进行洗脱时,离子交换柱层析能检测到一个具有谷氨酰胺转胺酶活性的蛋白吸收峰(图5A)。聚丙烯酰胺凝胶电泳图谱显示,具有谷氨酰胺转胺酶活性的蛋白样品中,谷氨酰胺转胺酶条带与其他杂蛋白条带距离较远(图5B)。The results showed that when 20 mM Tris-HCl eluent at pH 8.5 was used for elution, ion exchange column chromatography could detect a protein absorption peak with transglutaminase activity ( FIG. 5A ). The polyacrylamide gel electrophoresis pattern showed that in the protein sample with transglutaminase activity, the band of transglutaminase was far away from the bands of other miscellaneous proteins (Fig. 5B).
实施例7(昆虫谷氨酰胺转胺酶的纯化)Embodiment 7 (purification of insect transglutaminase)
方法1,具体包括如下步骤:Method 1 specifically includes the following steps:
(1)按照实施例1方法制备粘虫谷氨酰胺转胺酶的酶源。(1) Prepare the enzyme source of armyworm transglutaminase according to the method in Example 1.
(2)采用55%饱和度的硫酸铵进行蛋白沉淀,初步目标蛋白,装入透析袋中透析过夜。(2) Use ammonium sulfate with a saturation of 55% for protein precipitation, and put the target protein into a dialysis bag for dialysis overnight.
(3)采用Sephadex G-100凝胶柱进行层析,每15mL洗脱液收集一管,(3) Sephadex G-100 gel column is used for chromatography, and every 15mL eluent is collected in one tube,
(4)采用DEAE-纤维素-52离子交换柱层析(D2.6×20cm)和pH8.5洗脱缓冲液(4) Adopt DEAE-cellulose-52 ion exchange column chromatography (D2.6×20cm) and pH8.5 elution buffer
实验结果:Experimental results:
结果表明,经Sepadex G-100凝胶层析后,获得初步分离的含谷氨酰胺转胺酶活性的目的蛋白样品,谷氨酰胺转胺酶蛋白被纯化了5.683倍。该目的蛋白经浓缩后,经过DEAE-纤维素-52离子交换层析,大部分蛋白未被吸附而被洗脱,谷氨酰胺转胺酶蛋白被离子浓度约为0.5M的NaCl洗脱液洗脱,收集的谷氨酰胺转胺酶蛋白被纯化了48.36倍,最终回收率为12.69%。在聚丙烯酰胺凝胶电泳图谱中,目的蛋白仅显示一条清晰的谷氨酰胺转胺酶蛋白条带,分子量约为63.87kDa(图6),达到了蛋白的N-端测序纯度。缺点是蛋白的损失量较大,目的蛋白的回收率较低。The results showed that after Sepadex G-100 gel chromatography, the target protein sample containing transglutaminase activity was initially separated, and the transglutaminase protein was purified by 5.683 times. After the target protein is concentrated, it undergoes DEAE-cellulose-52 ion exchange chromatography, most of the protein is eluted without being adsorbed, and the transglutaminase protein is eluted by NaCl eluent with an ion concentration of about 0.5M The collected transglutaminase protein was purified by 48.36 times, and the final recovery rate was 12.69%. In the polyacrylamide gel electrophoresis profile, the target protein only showed a clear band of transglutaminase protein with a molecular weight of about 63.87kDa (Figure 6), which reached the N-terminal sequencing purity of the protein. The disadvantage is that the protein loss is large and the recovery rate of the target protein is low.
方法2,具体包括如下步骤:Method 2 specifically includes the following steps:
(1)按照实施例1方法制备粘虫谷氨酰胺转胺酶的酶源。(1) Prepare the enzyme source of armyworm transglutaminase according to the method in Example 1.
(2)采用55%饱和度的硫酸铵进行蛋白沉淀,初步目标蛋白,装入透析袋中透析过夜。(2) Use ammonium sulfate with a saturation of 55% for protein precipitation, and put the target protein into a dialysis bag for dialysis overnight.
(3)采用DEAE-纤维素-52离子交换柱进行层析,洗脱液为pH7.8的20mM Tris-HCl(含0-1.0M NaCl)缓冲液。(3) Chromatography was performed on a DEAE-cellulose-52 ion-exchange column, and the eluent was 20 mM Tris-HCl (containing 0-1.0 M NaCl) buffer at pH 7.8.
(4)采用DEAE-纤维素-52离子交换柱进行层析,洗脱液为pH8.25的Tris-HCl(含0-1.0M NaCl)缓冲液。(4) Chromatography was performed on a DEAE-cellulose-52 ion-exchange column, and the eluent was Tris-HCl (containing 0-1.0 M NaCl) buffer at pH 8.25.
(5)采用Sephadex G-100凝胶柱进行层析,收集目标蛋白。(5) Sephadex G-100 gel column is used for chromatography to collect the target protein.
实验结果:Experimental results:
结果表明,在第一次离子交换柱层析中,经pH7.8的20mM Tris-HCl(含0-1.0M的NaCl)缓冲液洗脱,在0.3M~0.8M的NaCl溶液的洗脱液条件下,含有谷氨酰胺转胺酶活性的蛋白被较大程度地解吸附洗脱,出现一个较大的蛋白吸收峰。该目的蛋白在第二次离子交换柱层析中,经pH8.25的20mM Tris-HCl(含0-1.0M NaCl)缓冲液洗脱,含有谷氨酰胺转胺酶活性的蛋白被0.3M~0.6M的NaCl溶液的洗脱液解吸附洗脱。进一步通过Sephadex G-100凝胶柱进行层析,收集的谷氨酰胺转胺酶蛋白被纯化了40.68倍,最终回收率为18.62%。但是,在聚丙烯酰胺凝胶电泳图谱中,目的蛋白的分子量约为63.17,而分子量约为56.68的杂蛋白没有被去除。优缺点是目的蛋白的回收率高,但存在少量杂蛋白。The results show that, in the first ion exchange column chromatography, after elution with 20mM Tris-HCl (containing 0-1.0M NaCl) buffer solution at pH 7.8, the eluent in 0.3M-0.8M NaCl solution Under the above conditions, the protein containing transglutaminase activity is desorbed and eluted to a greater extent, and a larger protein absorption peak appears. In the second ion exchange column chromatography, the target protein was eluted with 20mM Tris-HCl (containing 0-1.0M NaCl) buffer at pH 8.25, and the protein containing transglutaminase activity was eluted by 0.3M~1.0M NaCl. The eluent was desorbed and eluted with 0.6 M NaCl solution. After further chromatography on a Sephadex G-100 gel column, the collected transglutaminase protein was purified by 40.68 times, and the final recovery rate was 18.62%. However, in the polyacrylamide gel electrophoresis pattern, the molecular weight of the target protein is about 63.17, and the impurity protein with a molecular weight of about 56.68 is not removed. The advantage and disadvantage are that the recovery rate of the target protein is high, but there is a small amount of impurity protein.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610458931.5A CN106011099A (en) | 2016-06-23 | 2016-06-23 | Separation and purification method of insect transglutaminase |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610458931.5A CN106011099A (en) | 2016-06-23 | 2016-06-23 | Separation and purification method of insect transglutaminase |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106011099A true CN106011099A (en) | 2016-10-12 |
Family
ID=57086462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610458931.5A Pending CN106011099A (en) | 2016-06-23 | 2016-06-23 | Separation and purification method of insect transglutaminase |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106011099A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1769437A (en) * | 2005-07-13 | 2006-05-10 | 天津昂赛细胞基因工程有限公司 | Transglutaminase preparation method |
CN102120989A (en) * | 2010-12-10 | 2011-07-13 | 江南大学 | Novel transglutaminase and application thereof |
CN102146361A (en) * | 2011-02-01 | 2011-08-10 | 泰兴市一鸣生物制品有限公司 | Method for separating and purifying transglutaminase |
CN102776160A (en) * | 2012-08-06 | 2012-11-14 | 华东师范大学 | Method for separating and purifying microbial transglutaminase |
CN103409394A (en) * | 2013-07-13 | 2013-11-27 | 福建农林大学 | Method for separating and purifying Lecanicillium lecanii chitinase |
-
2016
- 2016-06-23 CN CN201610458931.5A patent/CN106011099A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1769437A (en) * | 2005-07-13 | 2006-05-10 | 天津昂赛细胞基因工程有限公司 | Transglutaminase preparation method |
CN102120989A (en) * | 2010-12-10 | 2011-07-13 | 江南大学 | Novel transglutaminase and application thereof |
CN102146361A (en) * | 2011-02-01 | 2011-08-10 | 泰兴市一鸣生物制品有限公司 | Method for separating and purifying transglutaminase |
CN102776160A (en) * | 2012-08-06 | 2012-11-14 | 华东师范大学 | Method for separating and purifying microbial transglutaminase |
CN103409394A (en) * | 2013-07-13 | 2013-11-27 | 福建农林大学 | Method for separating and purifying Lecanicillium lecanii chitinase |
Non-Patent Citations (1)
Title |
---|
邹佩贞等: "香菇谷氨酰胺转氨酶的分离和动力学研究", 《微生物学杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Filipek et al. | p30, a novel protein target of mouse calcyclin (S100A6) | |
JP2002302500A (en) | New protein and method for producing medicine using the same | |
ITMI20090831A1 (en) | EXTRACELLULAR IALURONIDASE FROM STREPTOMYCES KOGANEIENSIS | |
CN105017412A (en) | Method for separating high-purity bovine serum albumin from bovine serum | |
JPH03254683A (en) | Dna having genetic information of principal allergen of mite and its use | |
BRPI0616201A2 (en) | protein production and purification without using animal derived components | |
CN109810185A (en) | A kind of isolation and purification method of recombination human serum albumin | |
CN111072770B (en) | Ovotransferrin antibacterial peptide and preparation method thereof | |
CN109535227B (en) | Antibacterial peptide, preparation method of antibacterial peptide, antibacterial composition, antibacterial method and application | |
CN102796193A (en) | Method for extracting ovotransferrin from egg white | |
US20130225500A1 (en) | Analgesic active peptide vgg, preparation and use thereof | |
CN106011099A (en) | Separation and purification method of insect transglutaminase | |
CN105017407B (en) | A kind of purification process of recombinant human epidermal growth factor | |
CN115991763B (en) | Recombinant human III type collagen and preparation method and application thereof | |
CN1982457A (en) | Toxic sequential, its preparation and use | |
JPH04505162A (en) | Peptides that inhibit leukocyte elastase and cathepsin G, DNA, vectors, host organisms and methods of obtaining them, and pharmaceutical preparations containing the peptides | |
CN111004305B (en) | Agaricus blazei small peptide and its preparation method and application | |
CN116813712A (en) | Antibacterial peptide W33 with alpha-helical structure and rich in Trp, and preparation method and application thereof | |
JPH02288899A (en) | Hepatocyte growth factor (i) | |
CN110716035A (en) | A high-throughput drug screening method for anti-hydatid disease based on hydatid tubulin as the target | |
JPH05500809A (en) | Novel proteins and their production | |
CN113789319A (en) | Method and application of isolating maggot kinase from fly maggots | |
CN101927012B (en) | Virus inactivating method for nerve growth factors | |
CN108929365B (en) | Renaturation method of recombinant protein | |
CN1120365C (en) | Affinity medium and process for purifying albumin with said medium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161012 |